{"url_path":"/sec/md/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/893949/0001193125-26-304033-index.html","accession_number":"0001193125-26-304033","cik":"0000893949","ticker":"MD","issuer_name":"Pediatrix Medical Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/893949/0001193125-26-304033-index.html","primary_entity_key":"0000893949","primary_entity_name":"Pediatrix Medical Group, Inc."},"word_count":72,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\nd) Exhibits.\n\nExhibit Index\n\n99.1— [Press Release of Pediatrix Medical Group, Inc. dated July 15, 2026](md-ex99_1.htm).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nPediatrix Medical Group, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJuly 15, 2026\n\nBy:\n\n/s/ Kasandra H. Rossi\n\n \n\n \n\n \n\nKasandra H. Rossi\nChief Financial Officer"}